Thomas A. Marsland, MD

Dr. Thomas A. Marsland is board certified in medical oncology and internal medicine and practices at the Cancer Specialists of North Florida Fleming Island and Orange Park Cancer Centers.

Dr. Marsland’s areas of special interest include lung and prostate cancer. He is closely following new developing in both areas, both the current clinical trials for lung cancer and the new science for prostate cancer.

Dr. Marsland is optimistic about the future of cancer treatments, especially in the areas called target therapy and personalized care.

Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules involved in tumor growth and progression. Because scientists often call these molecules “molecular targets,” targeted cancer therapies are sometimes called “molecularly targeted drugs,” “molecularly targeted therapies,” or other similar names. Targeted cancer therapies are being studied for use alone, in combination with other targeted therapies, and in combination with other cancer treatments, such as chemotherapy.

Personalized care is a term for care that is tailored to the biology of individual patients and their cancers. Since there are more than 200 types of cancer, understanding the molecular basis of each is a critical step toward personalizing cancer care.

Dr. Marsland credits his “great patients” for his continuing commitment to the field of medical oncology, and his goal is to help improve and change their lives.

A native of Massachusetts, Dr. Marsland enjoys the warm Florida climate. When he’s not in Jacksonville, his favorite retreat is an island in the Caribbean.